Grant: Alliance Grants
McGill University
$25,000.00
Investigating the Structural Dynamics of an Enzyme Required for Survival of Archaeal Methanogens in the Human Gut
EF 2023-24
Résumé
Microorganisms (bacteria, archaea, and fungi) in the gastrointestinal tract play a critical role in numerous processes that impact human health. Perturbations in gut microorganism populations are correlated with numerous diseases including chronic intestinal inflammation, obesity, diabetes, atherosclerosis, neurological disorders, autoimmune diseases, and cancer. Many of these maladies are specifically associated with an over-proliferation of methanogenic archaea (methanogens) - a state known clinically as intestinal methanogenic overgrowth (IMO). Therapeutics that selectively target IMO and its associated pathologies are currently lacking. Methanogens rely on several unique enzymes to produce methane during their metabolism, and without proper function of these enzymes, methanogen survival in the gut is not possible. Therefore, inhibitors targeting these enzymes could potentially find application in the treatment of IMO. This proposal investigates the mechanism and function of one of these critical enzymes - the CfbCD enzyme complex. CfbCD catalyzes the sequential transfer of six electrons to a critical molecule (coenzyme F430) that is required for proper function of other methane metabolic enzymes. The electron transfers catalyzed by CfbCD are thought to be regulated by structural changes in the highly dynamic CfbCD protein complex. Understanding the nature of these conformational changes is critical for devising strategies to inhibit the enzyme and to shut down methanogenesis during IMO. The goal of this research is to define the molecular level details of these cryptic structural changes in the CfbCD complex using hydrogen-deuterium exchange mass spectrometry (HDX-MS) - a specialized biophysical technique that is ideally suited for investigating dynamic structural changes in enzymes. This research will provide fundamental knowledge on the structural mechanism of a complex metabolic enzyme that can be harnessed for the development of CfbCD inhibitors and treatments for IMO.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
590863-2023
Name nom
Thibodeaux, Christopher CJ
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochemistry
Research subject en
Biochimie
Research subject fr
Biochimie
Application title
Investigating the Structural Dynamics of an Enzyme Required for Survival of Archaeal Methanogens in the Human Gut
Keyword
allostery; biochemistry; biophysics; catalysis; conformational dynamics; enzymes; hydrogen-deuterium exchange; mass spectrometry; mechanism; metalloenzymes
Application summary
Microorganisms (bacteria, archaea, and fungi) in the gastrointestinal tract play a critical role in numerous processes that impact human health. Perturbations in gut microorganism populations are correlated with numerous diseases including chronic intestinal inflammation, obesity, diabetes, atherosclerosis, neurological disorders, autoimmune diseases, and cancer. Many of these maladies are specifically associated with an over-proliferation of methanogenic archaea (methanogens) - a state known clinically as intestinal methanogenic overgrowth (IMO). Therapeutics that selectively target IMO and its associated pathologies are currently lacking. Methanogens rely on several unique enzymes to produce methane during their metabolism, and without proper function of these enzymes, methanogen survival in the gut is not possible. Therefore, inhibitors targeting these enzymes could potentially find application in the treatment of IMO. This proposal investigates the mechanism and function of one of these critical enzymes - the CfbCD enzyme complex. CfbCD catalyzes the sequential transfer of six electrons to a critical molecule (coenzyme F430) that is required for proper function of other methane metabolic enzymes. The electron transfers catalyzed by CfbCD are thought to be regulated by structural changes in the highly dynamic CfbCD protein complex. Understanding the nature of these conformational changes is critical for devising strategies to inhibit the enzyme and to shut down methanogenesis during IMO. The goal of this research is to define the molecular level details of these cryptic structural changes in the CfbCD complex using hydrogen-deuterium exchange mass spectrometry (HDX-MS) - a specialized biophysical technique that is ideally suited for investigating dynamic structural changes in enzymes. This research will provide fundamental knowledge on the structural mechanism of a complex metabolic enzyme that can be harnessed for the development of CfbCD inhibitors and treatments for IMO.